Your browser doesn't support javascript.
loading
The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Lill, Christina M; Rengmark, Aina; Pihlstrøm, Lasse; Fogh, Isabella; Shatunov, Aleksey; Sleiman, Patrick M; Wang, Li-San; Liu, Tian; Lassen, Christina F; Meissner, Esther; Alexopoulos, Panos; Calvo, Andrea; Chio, Adriano; Dizdar, Nil; Faltraco, Frank; Forsgren, Lars; Kirchheiner, Julia; Kurz, Alexander; Larsen, Jan P; Liebsch, Maria; Linder, Jan; Morrison, Karen E; Nissbrandt, Hans; Otto, Markus; Pahnke, Jens; Partch, Amanda; Restagno, Gabriella; Rujescu, Dan; Schnack, Cathrin; Shaw, Christopher E; Shaw, Pamela J; Tumani, Hayrettin; Tysnes, Ole-Bjørn; Valladares, Otto; Silani, Vincenzo; van den Berg, Leonard H; van Rheenen, Wouter; Veldink, Jan H; Lindenberger, Ulman; Steinhagen-Thiessen, Elisabeth; Teipel, Stefan; Perneczky, Robert; Hakonarson, Hakon; Hampel, Harald; von Arnim, Christine A F; Olsen, Jørgen H; Van Deerlin, Vivianna M; Al-Chalabi, Ammar; Toft, Mathias; Ritz, Beate.
Afiliação
  • Lill CM; Platform for Genome Analytics, Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany. Electronic address: christina.lill@gmx.de.
  • Rengmark A; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Pihlstrøm L; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Fogh I; Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK.
  • Shatunov A; Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK.
  • Sleiman PM; Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, Universi
  • Wang LS; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Liu T; Max Planck Institute for Human Development, Berlin, Germany.
  • Lassen CF; Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
  • Meissner E; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Alexopoulos P; Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.
  • Calvo A; Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy.
  • Chio A; Rita Levi Montalcini Department of Neuroscience, ALS Center, University of Torino, Torino, Italy; Neuroscience Institute of Turin, Turin, Italy.
  • Dizdar N; Department of Neurology, Linköping University, Linköping, Sweden.
  • Faltraco F; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, Goethe University of Frankfurt, Frankfurt, Germany.
  • Forsgren L; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
  • Kirchheiner J; Department of Neurology, University of Ulm, Ulm, Germany.
  • Kurz A; Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany.
  • Larsen JP; The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
  • Liebsch M; Department of Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Linder J; Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.
  • Morrison KE; School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Neurosciences Division, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Nissbrandt H; Department of Pharmacology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Otto M; Department of Neurology, University of Ulm, Ulm, Germany.
  • Pahnke J; Department of Neuro-/Pathology, University of Oslo and Oslo University Hospital, Oslo, Norway; Lübeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Partch A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Restagno G; Department of Clinical Pathology, Molecular Genetics Unit, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy.
  • Rujescu D; Department of Psychiatry, University of Halle-Wittenberg, Halle, Germany.
  • Schnack C; Department of Neurology, University of Ulm, Ulm, Germany.
  • Shaw CE; Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK.
  • Shaw PJ; Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK.
  • Tumani H; Department of Neurology, University of Ulm, Ulm, Germany.
  • Tysnes OB; Department of Neurology, Haukeland University Hospital, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Valladares O; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Silani V; Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; Department of Pathophysiology and Tranplantation, "Dino Ferrari" Center, Università degli Studi di Milano, Milano, Italy.
  • van den Berg LH; Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van Rheenen W; Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Veldink JH; Department of Neurology, Neuromuscular Diseases Brain Center Rudolf Magnus, Netherlands ALS Center, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Lindenberger U; Max Planck Institute for Human Development, Berlin, Germany.
  • Steinhagen-Thiessen E; Interdisciplinary Metabolic Center, Lipids Clinic, Charité University Medicine, Berlin, Germany.
  • Teipel S; German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany; Department of Psychosomatic Medicine, University of Rostock, Rostock, Germany.
  • Perneczky R; Department of Psychiatry and Psychotherapy, Technische Universität München, Munich, Germany; Neuroepidemiology and Ageing Research Unit, School of Public Health, Faculty of Medicine, The Imperial College of Science, Technology, and Medicine, London, UK; West London Cognitive Disorders Treatment and
  • Hakonarson H; Center for Applied Genomics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Division of Human Genetics, Abramson Research Center, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, Perelman School of Medicine, Universi
  • Hampel H; AXA Research Fund & UPMC Chair, Paris, France; Département de Neurologie, Sorbonne Universités, Université Pierre et Marie Curie, Institut de la Mémoire et de la Maladie d'Alzheimer & Institut du Cerveau et de la Moelle épinière (ICM), Hôpital de la Pitié-Salpétrière, Paris, France.
  • von Arnim CAF; Department of Neurology, University of Ulm, Ulm, Germany.
  • Olsen JH; Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
  • Van Deerlin VM; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
  • Al-Chalabi A; Department of Clinical Neuroscience, Institute of Psychiatry, King's College London, London, UK.
  • Toft M; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Ritz B; Department of Epidemiology and Environmental Sciences, School of Public Health, University of California, Los Angeles, CA, USA.
Alzheimers Dement ; 11(12): 1407-1416, 2015 Dec.
Article em En | MEDLINE | ID: mdl-25936935
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Receptores Imunológicos / Doenças Neurodegenerativas / Predisposição Genética para Doença / Doença de Alzheimer Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteínas de Membrana / Receptores Imunológicos / Doenças Neurodegenerativas / Predisposição Genética para Doença / Doença de Alzheimer Idioma: En Ano de publicação: 2015 Tipo de documento: Article